Track Artelo Biosciences- Warrants (18/06/2024)'s current cash ($4.2M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), ARTLW shows a current cash of $4.2M. That compares with $2.1M in the prior-year period — up 103.2% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ARTLW's current cash is now $4.2M (was $2.1M) — a 103.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Artelo Biosciences- Warrants (18/06/2024) is outperforming or lagging.
Tracking ARTLW's current cash over time shows whether Artelo Biosciences- Warrants (18/06/2024) is scaling, shrinking, or reshaping that part of the business. The current reading is $4.2M That compares with $2.1M in the prior-year period — up 103.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has Artelo Biosciences- Warrants (18/06/2024)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $4.2M) with ownership activity and broader fundamentals.
Artelo Biosciences- Warrants (18/06/2024)'s current cash is $4.2M; compare it with other Consumer Staples names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.